Infectious Disease Platform

Capacity

  • Comprehensive virus, bacteria, fungi coverages
  • Supporting drug and vaccine discovery from early research to clinical trials

Capability

  • 20+ various viruses
  • Supporting discovery of antivirals and vaccines, including HBV, SARS-CoV,
    IFV, RSV, HCV, HIV, EV71, herpes, rabies, and other viruses
  • 130+ different bacterial and fungal species
  • Supporting discovery of antibacterial and antifungal therapeutics, including ESKAPE,
    Streptococcus, Neisseria, H. influenza, Anaerobes, H. pylori, Mycoplasma, and more
  • Opsonophagocytic assays: S. pneumoniae

Clinical Bioanalysis Platform

  • Molecular Testing Laboratory recognized with accreditation from CAP
  • Successfully cleared every CAP inspection; flawlessly passed all inspections from NMPA/FDA
  • Achieved one-time passing in proficiency testing (HBV DNA and HCV RNA viral load, UGT1A1 genotyping) endorsed by CAP, SCCL, and NCCL
  • Expertise in clinical virology, oncolytic virus pharmacokinetics (PK) and pharmacodynamics (PD), vaccine immune response analysis, cell therapy
    PK and PD assessments, AAV therapy, and advanced therapeutics


Infectious Disease Platform_Flyer

Download

← Return to Resources

Related Content

Human metapneumovirus (HMPV) is a common cause of respiratory tract infections in young children, older adults, and people with weakened...

VIEW RESOURCE

Cereblon (CRBN) forms an E3 ligase complex together with DDB1, CUL4, and RBX1. CRBN functions as a substrate receptor of...

VIEW RESOURCE
← View all Infectious Diseases Resources
× peptide, amino acid

Contact An Expert Today!